title: Enhanced external counterpulsation for ischemic heart disease:  a look behind the curtain.
abstract: Enhanced external counterpulsation (EECP) is a noninvasive treatment for patients with coronary artery disease who have angina pectoris that is refractory to pharmacotherapy and revascularization. The popular concept is that EECP may promote collateral development and improve myocardial perfusion. We hypothesize that improvements in peripheral arterial function are responsible for the clinical benefits of EECP.
authors.affiliation: Department of Applied Physiology and Kinesiology, College of Health and Human Performance, University of Florida, Gainesville, FL 32611, USA. rbraith@hhp.ufl.edu
authors.forename: Randy W
authors.initials: RW
authors.lastname: Braith
authors.forename: Darren P
authors.initials: DP
authors.lastname: Casey
authors.forename: Darren T
authors.initials: DT
authors.lastname: Beck
mesh_terms: D000787:Angina Pectoris / Q000628:therapy*; D003324:Coronary Artery Disease / Q000628:therapy*; D015908:Counterpulsation; D004730:Endothelium, Vascular / Q000502:physiology; D006801:Humans; D009206:Myocardium / Q000378:metabolism; D010100:Oxygen / Q000378:metabolism; D059289:Vascular Stiffness; D016277:Ventricular Function, Left
chemical_list: D010100:Oxygen